KALIF ELIYAHU SHARON (EVP, Chief Financial Officer) sold 85.7% of their position (345.81K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market
Open‑market sale worth $11.63M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/2/2026ACC: 0001193125-26-085343
Officer· EVP, Chief Financial Officer
Since Dec 2019
-345.81K
Net shares
Net seller
$11.63M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
345.81K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−345.81K
Price / share
$33.64
Trade value
$11.63M
% of position
85.7%
2/26/2026
403.29K→57.48K
Total
Net shares
−345.81K
Net value
-$11.63M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/26/2026 | S · Sale | −345.81K | $33.64 | $11.63M | 85.7% | 403.29K | 57.48K |
| Total | −345.81K | -$11.63M | ||||||
Derivative Transactions0
No derivative transactions reported